CAS 221231-10-3
AOD-9604 5 mg
Modified fragment of human growth hormone (176-191), studied in research on lipid metabolism.
£48.99 In stockOften ordered with
Lyophilised peptides are reconstituted with a laboratory diluent. Add it to the same parcel.
Bacteriostatic water 10 ml£10.99
Normal price, no bundle discount.
- Dispatched from UK stock
- Royal Mail Tracked 48
- No customs or import VAT
- 4 certificates
- Plain packaging
- Bank transfer or crypto
For laboratory research only. Not suitable for human consumption or veterinary use.
Description
AOD-9604 is a synthetic fragment of human growth hormone (residues 176 to 191). It is studied in laboratory models of lipid metabolism. Supplied for in vitro research only.
Specification
| CAS number | 221231-10-3 |
|---|---|
| Vial size | 5 mg |
| Purity | Specification ≥98%; the measured value is on the certificate of analysis for the lot |
| Molecular formula | C78H123N23O23S2 |
| Molar mass | 1815.10 g/mol |
| Sequence or identity | hGH fragment (176-191) analogue, 16 amino acids |
| Form | Lyophilised powder |
| Research area | Metabolic research |
| Storage | −20 °C, protected from light; after reconstitution, 2 to 8 °C |
Certificates of analysis
4 certificates from independent EU laboratories, newest first. The lot number is printed on your vial label.
- Lot 20252565 mg vialOpen PDFAnalysed 13/08/2025 · Purity >99.8% · Liquilabs s.r.o.
- Lot 20252485 mg vialwith mannitol, supersededOpen PDFAnalysed 28/04/2025 · Purity 99.51% · APIGENEX s.r.o.
- Lot 20252485 mg vialOpen PDFAnalysed 28/04/2025 · Purity 99.51% · APIGENEX s.r.o.
- Lot 20241925 mg vialOpen PDFAnalysed 03/12/2024 · Purity 97.28% · APIGENEX s.r.o.
Every certificate we hold is in the certificate library.
Published research
- Heffernan M et al. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice. Endocrinology, 2001. PubMed 11713213 · doi:10.1210/endo.142.12.8522
In obese mice, AOD9604 reduced body weight and fat; its lipolytic action did not act directly through the beta3-adrenergic receptor. - Ng FM et al. Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone. Horm Res, 2000. PubMed 11146367 · doi:10.1159/000053183
In obese Zucker rats, AOD9604 increased adipose lipolytic activity without the insulin-sensitivity effects seen with intact hGH.
Published laboratory and preclinical research, cited for scientific context only. It is not evidence of safety or effect in people.
Documentation
Every vial ships with a written specification. More on how lots are tested: Quality and testing · What a certificate of analysis shows · How purity is measured.
Questions about AOD-9604 5 mg
Is AOD-9604 5 mg intended for human use?
No. AOD-9604 5 mg is supplied exclusively for in vitro laboratory research. It is not a medicine, food supplement or cosmetic and must not be administered to people or animals.
What purity does AOD-9604 5 mg have?
The specification is at least 98%. The latest lot with a measured value, 2025256, was analysed on 13/08/2025 by Liquilabs s.r.o. at >99.8%.
How should AOD-9604 5 mg be stored?
At −20 °C, protected from light; after reconstitution, 2 to 8 °C.
How is AOD-9604 5 mg shipped?
From UK stock by Royal Mail Tracked 48, in plain packaging, once payment has arrived. Royal Mail aims to deliver in 2 to 3 working days. Free delivery from £25.
Related products
